Sugammadex Injection, Solution
Product Images NDC 70069-892

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Sugammadex (NDC 70069-892). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (7df3ab09 27b2 4043 8d0a E20dd2a8807e 01)

Chemical structure diagram of sugammadex showing its cyclic molecular arrangement with multiple sodium carboxylate groups and sulfur atoms. The structure highlights hydroxyl groups and ether linkages within the molecule.*

FDA Label Image

Image (7df3ab09 27b2 4043 8d0a E20dd2a8807e 02)

Chemical structure of sugammadex, showing a cyclic molecular arrangement with multiple hydroxyl (OH) groups, sodium carboxylate (CO2Na) groups, and sulfur atoms forming thioether linkages.*

FDA Label Image

Image (7df3ab09 27b2 4043 8d0a E20dd2a8807e 03)

A cumulative recovery rate chart comparing sugammadex 2 mg/kg and neostigmine 0.05 mg/kg over time to recovery in minutes for patients receiving rocuronium. The x-axis represents time to recovery (minutes), and the y-axis shows cumulative recovery rate. The chart indicates faster recovery with sugammadex, with median recovery times of 1.4 minutes vs. 21.5 minutes for neostigmine.*

FDA Label Image

Image (7df3ab09 27b2 4043 8d0a E20dd2a8807e 04)

A cumulative recovery rate chart comparing sugammadex 2 mg/kg and neostigmine 0.05 mg/kg over time in minutes. The graph plots cumulative recovery rate on the y-axis against time to recovery on the x-axis, showing faster recovery with sugammadex compared to neostigmine. Median recovery times with quartiles are summarized in an inset.*

FDA Label Image

Image (7df3ab09 27b2 4043 8d0a E20dd2a8807e 05)

Packaging label for Sugammadex Injection 200 mg/2 mL (100 mg/mL) intravenous solution by Somerset Therapeutics, LLC. The label states the product is for intravenous use only and comes in 10 single-dose 2 mL vials. The label includes instructions to discard unused portions and lists the NDC as 70069-892-10.*

FDA Label Image

Image (7df3ab09 27b2 4043 8d0a E20dd2a8807e 06)

Packaging label for Sugammadex Injection 500 mg/5 mL (100 mg/mL) solution for intravenous use. The label indicates 10 single-dose 5 mL vials. Manufactured by Somerset Therapeutics LLC, the label includes dosage strength, administration route, discard instructions, and some formulation details, including pH adjustment and osmolality.*

FDA Label Image

Image (7df3ab09 27b2 4043 8d0a E20dd2a8807e 07)

Label for Sugammadex Injection 200 mg/2 mL (100 mg/mL) single-dose vial for intravenous use. The label includes dosage strength, storage instructions at 25°C (77°F), and is manufactured for Somerset Therapeutics, LLC, Somerset, NJ. The vial volume is 2 mL with a peel-off label section for syringe application.*

FDA Label Image

Image (7df3ab09 27b2 4043 8d0a E20dd2a8807e 08)

Label for Sugammadex Injection 500 mg/5 mL (100 mg/mL) single-dose vial for intravenous use. The label specifies it is a 5 mL vial, manufactured for Somerset Therapeutics, LLC. Storage instructions include protection from light and a temperature of 25°C (77°F). The label includes a barcode and notes the product is made in Germany.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.